Firebrick Pharma (ASX:FRE) decided not to proceed with a previously proposed share placement, following the company's request to be placed in a trading halt pending the announcement of the placement, according to a June 6 filing with the Australian bourse.

On June 5, the company said the trading halt will remain in effect until the earlier of the start of normal trading on Tuesday or the release of the disclosure.